Telocytes and lung disease

Histology and Histopathology

Volumn 31, Issue 12, 2016, Pages 1303-1314

  Song, Dongli ^a   Cretoiu, Dragos ^b,c   Cretoiu, Sanda M ^b,c   Wang, Xiangdong ^a  

^a FUDAN UNIVERSITY   (China)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

Author keywords

Chronic obstructive pulmonary disease; Interstitial lung disease; Lung cancer; Pulmonary fibrosis; Telocytes

Indexed keywords

ANIMAL; HUMAN; LUNG DISEASE; PATHOPHYSIOLOGY; TELOCYTE;

ANIMALS; HUMANS; LUNG DISEASES; TELOCYTES;

EID: 84988896895     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: 10.14670/HH-11-807     Document Type: Review

References (118)

1. Agrawal A. and Mabalirajan U. (2016). Rejuvenating cellular respiration for optimizing respiratory function: Targeting mitochondria. Am. J. Physiol. Lung Cell Mol. Physiol. 310, L103-113.
2. Agusti A.G. (2005). COPD, a multicomponent disease: Implications for management. Respir. Med. 99, 670-682.
3. Albulescu R., Tanase C., Codrici E., Popescu D.I., Cretoiu S.M. and Popescu L.M. (2015). The secretome of myocardial telocytes modulates the activity of cardiac stem cells. J. Cell Mol. Med. 19, 1783-1794.
4. Alunno A., Ibba-Manneschi L., Bistoni O., Rosa I., Caterbi S., Gerli R. and Manetti M. (2015). Telocytes in minor salivary glands of primary sjogren's syndrome: Association with the extent of inflammation and ectopic lymphoid neogenesis. J. Cell Mol. Med. 19, 1689-1696.
5. Bagnato G. and Harari S. (2015). Cellular interactions in the pathogenesis of interstitial lung diseases. Eur. Respir. Rev. 24, 102-114.
6. Barnes P.J., Dweik R.A., Gelb A.F., Gibson P.G., George S.C., Grasemann H., Pavord I.D., Ratjen F., Silkoff P.E., Taylor D.R. and Zamel N. (2010). Exhaled nitric oxide in pulmonary diseases: A comprehensive review. Chest 138, 682-692.
7. Bei Y., Zhou Q., Fu S., Lv D., Chen P., Chen Y., Wang F. and Xiao J. (2015). Cardiac telocytes and fibroblasts in primary culture: Different morphologies and immunophenotypes. PLoS One 10, e0115991.
8. Blanc P.D. and Toren K. (2016). COPD and occupation: Resetting the agenda. Occup. Environ. Med. 73, 357-358.
9. Brusasco V. and Martinez F. (2014). Chronic obstructive pulmonary disease. Compr. Physiol. 4, 1-31.
10. Butt Y., Kurdowska A. and Allen T.C. (2016). Acute lung injury: A clinical and molecular review. Arch. Pathol. Lab. Med. 140, 345-350.
11. Campeanu R.A., Radu B.M., Cretoiu S.M., Banciu D.D., Banciu A., Cretoiu D. and Popescu L.M. (2014). Near-infrared low-level laser stimulation of telocytes from human myometrium. Lasers Med. Sci. 29, 1867-1874.
12. Ceafalan L., Gherghiceanu M., Popescu L.M. and Simionescu O. (2012). Telocytes in human skin--are they involved in skin regeneration? J. Cell Mol. Med. 16, 1405-1420.
13. Chang Y., Li C., Lu Z., Li H. and Guo Z. (2015). Multiple immunophenotypes of cardiac telocytes. Exp. Cell Res. 338, 239-244.
14. Cherniack R.M. (1970). The management of acute respiratory failure. Chest 58 (Suppl 2), 427-436.
15. Chiumello D., Coppola S., Froio S. and Gotti M. (2016). What's next after ARDS: Long-term outcomes. Respir. Care 61, 689-699.
16. Choi D.S., Kim D.K., Kim Y.K. and Gho Y.S. (2013). Proteomics, transcriptomics and lipidomics of exosomes and ectosomes. Proteomics 13, 1554-1571.
17. Choi D.S., Kim D.K., Kim Y.K. and Gho Y.S. (2015). Proteomics of extracellular vesicles: Exosomes and ectosomes. Mass. Spectrom. Rev. 34, 474-490.
18. Ciontea S.M., Radu E., Regalia T., Ceafalan L., Cretoiu D., Gherghiceanu M., Braga R.I., Malincenco M., Zagrean L., Hinescu M.E. and Popescu L.M. (2005). C-kit immunopositive interstitial cells (cajal-type) in human myometrium. J. Cell Mol. Med. 9, 407-420.
19. Cismasiu V.B. and Popescu L.M. (2015). Telocytes transfer extracellular vesicles loaded with microRNAs to stem cells. J. Cell Mol. Med. 19, 351-358.
20. Cismasiu V.B., Radu E. and Popescu L.M. (2011). Mir-193 expression differentiates telocytes from other stromal cells. J. Cell Mol. Med. 15, 1071-1074.
21. Coleman B.M., Hanssen E., Lawson V.A. and Hill A.F. (2012). Prioninfected cells regulate the release of exosomes with distinct ultrastructural features. FASEB J. 26, 4160-4173.
22. Corradi L.S., Jesus M.M., Fochi R.A., Vilamaior P.S., Justulin L.A. Jr., Goes R.M., Felisbino S.L. and Taboga S.R. (2013). Structural and ultrastructural evidence for telocytes in prostate stroma. J. Cell Mol. Med. 17, 398-406.
23. Cretoiu D. and Cretoiu S.M. (2016). Telocytes in the reproductive organs: Current understanding and future challenges. Semin. Cell Dev. Biol. 55, 40-49.
24. Cretoiu S.M. and Popescu L.M. (2014). Telocytes revisited. Biomol. Concepts. 5, 353-369.
25. Cretoiu D., Ciontea S.M., Popescu L.M., Ceafalan L. and Ardeleanu C. (2006). Interstitial cajal-like cells (ICLC) as steroid hormone sensors in human myometrium: Immunocytochemical approach. J. Cell Mol. Med. 10, 789-795.
26. Cretoiu D., Cretoiu S.M., Simionescu A.A. and Popescu L.M. (2012a). Telocytes, a distinct type of cell among the stromal cells present in the lamina propria of jejunum. Histol. Histopathol. 27, 1067-1078.
27. Cretoiu S.M., Cretoiu D. and Popescu L.M. (2012b). Human myometrium-the ultrastructural 3D network of telocytes. J. Cell Mol. Med. 16, 2844-2849.
28. Cretoiu S.M., Cretoiu D., Marin A., Radu B.M. and Popescu L.M. (2013). Telocytes: Ultrastructural, immunohistochemical and electrophysiological characteristics in human myometrium. Reproduction 145, 357-370.
29. Cretoiu D., Hummel E., Zimmermann H., Gherghiceanu M. and Popescu L.M. (2014). Human cardiac telocytes: 3D imaging by FIBSEM tomography. J. Cell Mol. Med. 18, 2157-2164.
30. Cretoiu D., Gherghiceanu M., Hummel E., Zimmermann H., Simionescu O. and Popescu L.M. (2015a). FIB-SEM tomography of human skin telocytes and their extracellular vesicles. J. Cell Mol. Med. 19, 714-722.
31. Cretoiu S.M., Radu B.M., Banciu A., Banciu D.D., Cretoiu D., Ceafalan L.C. and Popescu L.M. (2015b). Isolated human uterine telocytes: Immunocytochemistry and electrophysiology of t-type calcium channels. Histochem. Cell Biol. 143, 83-94.
32. Danesh M.J., Saylor D.K., Leard L.E., North J.P. and Fox L.P. (2016). Acquired acanthosis nigricans with tripe palms in a patient with interstitial lung disease. JAAD Case Rep. 2, 59-62.
33. Diaz-Flores L., Gutierrez R., Saez F.J., Diaz-Flores L. Jr. and Madrid J.F. (2013). Telocytes in neuromuscular spindles. J. Cell Mol. Med. 17, 457-465.
34. Diaz-Flores L., Gutierrez R., Garcia M.P., Saez F.J., Diaz-Flores L. Jr., Valladares F. and Madrid J.F. (2014). Cd34+ stromal cells/ fibroblasts/fibrocytes/telocytes as a tissue reserve and a principal source of mesenchymal cells. Location, morphology, function and role in pathology. Histol. Histopathol. 29, 831-870.
35. Dong H., Li J., Lv Y., Zhou Y., Wang G., Hu S., He X., Yang P., Zhou Z., Xiang X. and Wang C.Y. (2013). Comparative analysis of the alveolar macrophage proteome in ali/ards patients between the exudative phase and recovery phase. BMC Immunol. 14, 25.
36. Duquette R.A., Shmygol A., Vaillant C., Mobasheri A., Pope M., Burdyga T. and Wray S. (2005). Vimentin-positive, c-kit-negative interstitial cells in human and rat uterus: A role in pacemaking? Biol. Reprod. 72, 276-283.
37. Faussone-Pellegrini M.S. and Gherghiceanu M. (2016). Telocyte's contacts. Semin. Cell Dev. Biol. 55, 3-8.
38. Fertig E.T., Gherghiceanu M. and Popescu L.M. (2014). Extracellular vesicles release by cardiac telocytes: Electron microscopy and electron tomography. J. Cell Mol. Med. 18, 1938-1943.
39. Gavard J. and Gutkind J.S. (2006). VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of ve-cadherin. Nat. Cell Biol. 8, 1223-1234.
40. GBD 2013 Mortality and Causes of Death Collaborators (2015). Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the global burden of disease study 2013. Lancet 385, 117-171.
41. Gevaert T., De Vos R., Van Der Aa F., Joniau S., van den Oord J., Roskams T. and De Ridder D. (2012). Identification of telocytes in the upper lamina propria of the human urinary tract. J. Cell Mol. Med. 16, 2085-2093.
42. Hashisako M. and Fukuoka J. (2015). Pathology of idiopathic interstitial pneumonias. Clin. Med. Insights Circ. Respir. Pulm. Med. 9, 123-133.
43. Hinescu M.E., Gherghiceanu M., Mandache E., Ciontea S.M. and Popescu L.M. (2006). Interstitial cajal-like cells (ICLC) in atrial myocardium: Ultrastructural and immunohistochemical characterization. J. Cell Mol. Med. 10, 243-257.
44. Hinescu M.E., Gherghiceanu M., Suciu L. and Popescu L.M. (2011). Telocytes in pleura: Two-and three-dimensional imaging by transmission electron microscopy. Cell Tissue Res. 343, 389-397.
45. Hole D.J., Watt G.C., Davey-Smith G., Hart C.L., Gillis C.R. and Hawthorne V.M. (1996). Impaired lung function and mortality risk in men and women: Findings from the renfrew and paisley prospective population study. BMJ 313, 711-715; discussion 715-716.
46. Horch R.E., Boos A.M., Quan Y., Bleiziffer O., Detsch R., Boccaccini A.R., Alexiou C., Sun J., Beier J.P. and Arkudas A. (2013). Cancer research by means of tissue engineering-is there a rationale? J. Cell Mol. Med. 17, 1197-1206.
47. Hu Y., Wang L.S., Wei Y.R., Du S.S., Du Y.K., He X., Li N., Zhou Y., Li Q.H., Su Y.L., Zhang F., Shen L., Weng D., Brown K.K. and Li H.P. (2016). Clinical characteristics of connective tissue diseaseassociated interstitial lung disease in 1,044 chinese patients. Chest 149, 201-208.
48. Hunter M.P., Ismail N., Zhang X., Aguda B.D., Lee E.J., Yu L., Xiao T., Schafer J., Lee M.L., Schmittgen T.D., Nana-Sinkam S.P., Jarjoura D. and Marsh C.B. (2008). Detection of microrna expression in human peripheral blood microvesicles. PLoS One 3, e3694.
49. Hutchinson J., Fogarty A., Hubbard R. and McKeever T. (2015). Global incidence and mortality of idiopathic pulmonary fibrosis: A systematic review. Eur. Respir. J. 46, 795-806.
50. Ibba-Manneschi L., Rosa I. and Manetti M. (2016). Telocyte implications in human pathology: An overview. Semin. Cell Dev. Biol. 55, 62-69.
51. Kalra H., Simpson R.J., Ji H., Aikawa E., Altevogt P., Askenase P., Bond V.C., Borras F.E., Breakefield X., Budnik V., Buzas E., Camussi G., Clayton A., Cocucci E., Falcon-Perez J.M., Gabrielsson S., Gho Y.S., Gupta D., Harsha H.C., Hendrix A., Hill A.F., Inal J.M., Jenster G., Kramer-Albers E.M., Lim S.K., Llorente A., Lotvall J., Marcilla A., Mincheva-Nilsson L., Nazarenko I., Nieuwland R., Nolte-'t Hoen E.N., Pandey A., Patel T., Piper M.G., Pluchino S., Prasad T.S., Rajendran L., Raposo G., Record M., Reid G.E., Sanchez-Madrid F., Schiffelers R.M., Siljander P., Stensballe A., Stoorvogel W., Taylor D., Thery C., Valadi H., van Balkom B.W., Vazquez J., Vidal M., Wauben M.H., Yanez-Mo M., Zoeller M. and Mathivanan S. (2012). Vesiclepedia: A compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 10, e1001450.
52. Kostin S. (2016). Cardiac telocytes in normal and diseased hearts. Semin Cell Dev Biol. 55, 22-30.
53. Lazaar A.L. and Greenhaff P.L. (2012). Impaired muscle mitochondrial density and/or function: A COPD-specific mitochondropathy or simply deconditioning? Eur. Respir. J. 40, 1070-1071.
54. Liu M., Zeng X., Wang J., Fu Z., Wang J., Liu M., Ren D., Yu B., Zheng L., Hu X., Shi W. and Xu J. (2016). Immunomodulation by mesenchymal stem cells in treating human autoimmune diseaseassociated lung fibrosis. Stem Cell Res. Ther. 7, 63.
55. Luesma M.J., Gherghiceanu M. and Popescu L.M. (2013). Telocytes and stem cells in limbus and uvea of mouse eye. J. Cell Mol. Med. 17, 1016-1024.
56. Manetti M., Rosa I., Messerini L., Guiducci S., Matucci-Cerinic M. and Ibba-Manneschi L. (2014). A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis. J. Cell Mol. Med. 18, 253-262.
57. Manetti M., Guiducci S., Ruffo M., Rosa I., Faussone-Pellegrini M.S., Matucci-Cerinic M. and Ibba-Manneschi L. (2013). Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis. J. Cell Mol. Med. 17, 482-496.
58. Manetti M., Rosa I., Messerini L. and Ibba-Manneschi L. (2015). Telocytes are reduced during fibrotic remodelling of the colonic wall in ulcerative colitis. J. Cell Mol. Med. 19, 62-73.
59. Manole C.G., Gherghiceanu M. and Simionescu O. (2015). Telocyte dynamics in psoriasis. J. Cell Mol. Med. 19, 1504-1519.
60. Milia A.F., Ruffo M., Manetti M., Rosa I., Conte D., Fazi M., Messerini L. and Ibba-Manneschi L. (2013). Telocytes in crohn's disease. J. Cell Mol. Med. 17, 1525-1536.
61. Mou Y., Wang Y., Li J., Lu S., Duan C., Du Z., Yang G., Chen W., Zhao S., Zhou J. and Wang C. (2013). Immunohistochemical characterization and functional identification of mammary gland telocytes in the self-assembly of reconstituted breast cancer tissue in vitro. J. Cell Mol. Med. 17, 65-75.
62. Murdoch J.R. and Lloyd C.M. (2010). Chronic inflammation and asthma. Mutat. Res. 690, 24-39.
63. Papazian L., Calfee C.S., Chiumello D., Luyt C.E., Meyer N.J., Sekiguchi H., Matthay M.A. and Meduri G.U. (2016). Diagnostic workup for ards patients. Intensive Care Med. 42, 674-685.
64. Penfornis P., Vallabhaneni K.C., Whitt J. and Pochampally R. (2016). Extracellular vesicles as carriers of microrna, proteins and lipids in tumor microenvironment. Int. J. Cancer 138, 14-21.
65. Popescu L.M. (2011a). Telocytes and stem cells: A tandem in cardiac regenerative medicine. Curr. Med. Chem. 18, 94.
66. Popescu L.M. ( 2011b). The tandem: Telocytes-stem cells. Int. J. Biol. Biomed. Eng. 5, 83-92.
67. Popescu L.M. and Faussone-Pellegrini M.S. (2010). Telocytes-a case of serendipity: The winding way from interstitial cells of cajal (ICC), via interstitial cajal-like cells (ICLC) to telocytes. J. Cell Mol. Med. 14, 729-740.
68. Popescu L.M., Gherghiceanu M., Cretoiu D. and Radu E. (2005a). The connective connection: Interstitial cells of cajal (ICC) and ICC-like cells establish synapses with immunoreactive cells. Electron microscope study in situ. J. Cell Mol. Med. 9, 714-730.
69. Popescu L.M., Hinescu M.E., Ionescu N., Ciontea S.M., Cretoiu D. and Ardelean C. (2005b). Interstitial cells of cajal in pancreas. J. Cell Mol. Med. 9, 169-190.
70. Popescu L.M., Ciontea S.M., Cretoiu D., Hinescu M.E., Radu E., Ionescu N., Ceausu M., Gherghiceanu M., Braga R.I., Vasilescu F., Zagrean L. and Ardeleanu C. (2005c). Novel type of interstitial cell (cajal-like) in human fallopian tube. J. Cell Mol. Med. 9, 479-523.
71. Popescu L.M., Manole C.G., Gherghiceanu M., Ardelean A., Nicolescu M.I., Hinescu M.E. and Kostin S. (2010). Telocytes in human epicardium. J. Cell Mol. Med. 14, 2085-2093.
72. Popescu L.M., Gherghiceanu M., Suciu L.C., Manole C.G. and Hinescu M.E. (2011a). Telocytes and putative stem cells in the lungs: Electron microscopy, electron tomography and laser scanning microscopy. Cell Tissue Res. 345, 391-403.
73. Popescu L.M., Manole E., Serboiu C.S., Manole C.G., Suciu L.C., Gherghiceanu M. and Popescu B.O. (2011b). Identification of telocytes in skeletal muscle interstitium: Implication for muscle regeneration. J. Cell Mol. Med. 15, 1379-1392.
74. Popescu L.M., Curici A., Wang E., Zhang H., Hu S. and Gherghiceanu M. (2015). Telocytes and putative stem cells in ageing human heart. J. Cell Mol. Med. 19, 31-45.
75. Popescu L.M., Fertig E.T. and Gherghiceanu M. (2016). Reaching out: Junctions between cardiac telocytes and cardiac stem cells in culture. J. Cell Mol. Med. 20, 370-380.
76. Quail D.F. and Joyce J.A. (2013). Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423-1437.
77. Raghu G., Collard H.R., Egan J.J., Martinez F.J., Behr J., Brown K.K., Colby T.V., Cordier J.F., Flaherty K.R., Lasky J.A., Lynch D.A., Ryu J.H., Swigris J.J., Wells A.U., Ancochea J., Bouros D., Carvalho C., Costabel U., Ebina M., Hansell D.M., Johkoh T., Kim D.S., King T.E. Jr., Kondoh Y., Myers J., Muller N.L., Nicholson A.G., Richeldi L., Selman M., Dudden R.F., Griss B.S., Protzko S.L., Schunemann H.J. and ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis (2011). An official ats/ers/jrs/alat statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J. Respir. Crit. Care Med. 183, 788-824.
78. Roatesi I., Radu B.M., Cretoiu D. and Cretoiu S.M. (2015). Uterine telocytes: A review of current knowledge. Biol. Reprod. 93, 10.
79. Rodriguez-Suarez E., Gonzalez E., Hughes C., Conde-Vancells J., Rudella A., Royo F., Palomo L., Elortza F., Lu S.C., Mato J.M., Vissers J.P. and Falcon-Perez J.M. (2014). Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicity. J. Proteomics 103, 227-240.
80. Rusu M.C., Pop F., Hostiuc S., Curca G.C., Jianu A.M. and Paduraru D. (2012). Telocytes form networks in normal cardiac tissues. Histol. Histopathol. 27, 807-816.
81. Rusu M.C., Cretoiu D., Vrapciu A.D., Hostiuc S., Dermengiu D., Manoiu V.S., Cretoiu S.M. and Mirancea N. (2016). Telocytes of the human adult trigeminal ganglion. Cell. Biol. Toxicol. 32, 199-207.
82. Salama N.M. (2013). Immunohistochemical characterization of telocytes in rat uterus in different reproductive states. Egypt. J. Histol. 36, 185-194.
83. Selman M. and Pardo A. (2014). Revealing the pathogenic and agingrelated mechanisms of the enigmatic idiopathic pulmonary fibrosis. An integral model. Am. J. Respir. Crit. Care Med. 189, 1161-1172.
84. Semenova E.A., Nagel R. and Berns A. (2015). Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes Dev. 29, 1447-1462.
85. Sgalla G., Biffi A. and Richeldi L. (2016). Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural history. Respirology 21, 427-437.
86. Sheng J., Shim W., Lu J., Lim S.Y., Ong B.H., Lim T.S., Liew R., Chua Y.L. and Wong P. (2014). Electrophysiology of human cardiac atrial and ventricular telocytes. J. Cell Mol. Med. 18, 355-362.
87. Smythies J. (2015). Intercellular signaling in cancer-the smt and toft hypotheses, exosomes, telocytes and metastases: Is the messenger in the message? J. Cancer 6, 604-609.
88. Song D., Cretoiu D., Zheng M., Qian M., Zhang M., Cretoiu S.M., Chen L., Fang H., Popescu L.M. and Wang X. (2016). Comparison of chromosome 4 gene expression profile between lung telocytes and other local cell types. J. Cell Mol. Med. 20, 71-80.
89. Soulitzis N., Neofytou E., Psarrou M., Anagnostis A., Tavernarakis N., Siafakas N. and Tzortzaki E.G. (2012). Downregulation of lung mitochondrial prohibitin in copd. Respir. Med. 106, 954-961.
90. Spagnolo P., Rossi G. and Cavazza A. (2014a). Pathogenesis of idiopathic pulmonary fibrosis and its clinical implications. Expert Rev. Clin. Immunol. 10, 1005-1017.
91. Spagnolo P., Grunewald J. and du Bois R.M. (2014b). Genetic determinants of pulmonary fibrosis: Evolving concepts. Lancet Respir. Med. 2, 416-428.
92. Spagnolo P., Sverzellati N., Rossi G., Cavazza A., Tzouvelekis A., Crestani B. and Vancheri C. (2015). Idiopathic pulmonary fibrosis: An update. Ann. Med. 47, 15-27.
93. Stallberg B., Janson C., Johansson G., Larsson K., Stratelis G., Telg G. and Lisspers K.H. (2014). Management, morbidity and mortality of COPD during an 11-year period: An observational retrospective epidemiological register study in sweden (pathos). Prim. Care Respir. J. 23, 38-45.
94. Sun X., Zheng M., Zhang M., Qian M., Zheng Y., Li M., Cretoiu D., Chen C., Chen L., Popescu L.M. and Wang X. (2014). Differences in the expression of chromosome 1 genes between lung telocytes and other cells: Mesenchymal stem cells, fibroblasts, alveolar type ii cells, airway epithelial cells and lymphocytes. J. Cell Mol. Med. 18, 801-810.
95. Szefler S.J., Wenzel S., Brown R., Erzurum S.C., Fahy J.V., Hamilton R.G., Hunt J.F., Kita H., Liu A.H., Panettieri R.A. Jr., Schleimer R.P. and Minnicozzi M. (2012). Asthma outcomes: Biomarkers. J. Allergy Clin. Immunol. 129, S9-23.
96. Tao L., Wang H., Wang X., Kong X. and Li X. (2015). Cardiac telocytes. Curr. Stem Cell Res. Ther. 11, 404-409.
97. Torre L.A., Bray F., Siegel R.L., Ferlay J., Lortet-Tieulent J. and Jemal A. (2015). Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87-108.
98. Vannucchi M.G., Traini C., Manetti M., Ibba-Manneschi L. and Faussone-Pellegrini M.S. (2013). Telocytes express pdgfralpha in the human gastrointestinal tract. J. Cell Mol. Med. 17, 1099-1108.
99. Vestbo J., Hurd S.S., Agusti A.G., Jones P.W., Vogelmeier C., Anzueto A., Barnes P.J., Fabbri L.M., Martinez F.J., Nishimura M., Stockley R.A., Sin D.D. and Rodriguez-Roisin R. (2013). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Gold executive summary. Am. J. Respir. Crit. Care Med. 187, 347-365.
100. Wallace B., Vummidi D. and Khanna D. (2016). Management of connective tissue diseases associated interstitial lung disease: A review of the published literature. Curr. Opin. Rheumatol. 28, 236-245.
101. Wang J., Ye L., Jin M. and Wang X. (2015). Global analyses of chromosome 17 and 18 genes of lung telocytes compared with mesenchymal stem cells, fibroblasts, alveolar type II cells, airway epithelial cells, and lymphocytes. Biol. Direct. 10, 9.
102. Xiao J., Wang F., Liu Z. and Yang C. (2013). Telocytes in liver: Electron microscopic and immunofluorescent evidence. J. Cell Mol. Med. 17, 1537-1542.
103. Yang Y., Sun W., Wu S.M., Xiao J. and Kong X. (2014). Telocytes in human heart valves. J. Cell Mol. Med. 18, 759-765.
104. Yang X.J., Yang J., Liu Z., Yang G. and Shen Z.J. (2015). Telocytes damage in endometriosis-affected rat oviduct and potential impact on fertility. J. Cell Mol. Med. 19, 452-462.
105. Yue L. and Yao H. (2016). Mitochondrial dysfunction in inflammatory responses and cellular senescence: Pathogenesis and pharmacological targets for chronic lung diseases. Br. J. Pharmacol. 173, 2305-2318.
106. Zhao B., Chen S., Liu J., Yuan Z., Qi X., Qin J., Zheng X., Shen X., Yu Y., Qnin T.J., Chan J.Y. and Cai D. (2013). Cardiac telocytes were decreased during myocardial infarction and their therapeutic effects for ischaemic heart in rat. J. Cell Mol. Med. 17, 123-133.
107. Zhao B., Liao Z., Chen S., Yuan Z., Yilin C., Lee K.K., Qi X., Shen X., Zheng X., Quinn T. and Cai D. (2014). Intramyocardial transplantation of cardiac telocytes decreases myocardial infarction and improves post-infarcted cardiac function in rats. J. Cell Mol. Med. 18, 780-789.
108. Zheng Y., Li H., Manole C.G., Sun A., Ge J. and Wang X. (2011). Telocytes in trachea and lungs. J. Cell Mol. Med. 15, 2262-2268.
109. Zheng Y., Bai C. and Wang X. (2012a). Telocyte morphologies and potential roles in diseases. J. Cell Physiol. 227, 2311-2317.
110. Zheng Y., Zhu T., Lin M., Wu D. and Wang X. (2012b). Telocytes in the urinary system. J. Transl. Med. 10, 188.
111. Zheng Y.H., Li H., Ge J.B., Gao H.J. and Wang X.D. (2012c). Location of telocytes in mouse bronchial and pulmonary tissues. Zhonghua Bing Li Xue Za Zhi 41, 172-175 (in chinese).
112. Zheng Y., Zhang M., Qian M., Wang L., Cismasiu V.B., Bai C., Popescu L.M. and Wang X. (2013). Genetic comparison of mouse lung telocytes with mesenchymal stem cells and fibroblasts. J. Cell Mol. Med. 17, 567-577.
113. Zheng M., Sun X., Zhang M., Qian M., Zheng Y., Li M., Cretoiu S.M., Chen C., Chen L., Cretoiu D., Popescu L.M., Fang H. and Wang X. (2014a). Variations of chromosomes 2 and 3 gene expression profiles among pulmonary telocytes, pneumocytes, airway cells, mesenchymal stem cells and lymphocytes. J. Cell Mol. Med. 18, 2044-2060.
114. Zheng Y., Cretoiu D., Yan G., Cretoiu S.M., Popescu L.M. and Wang X. (2014b). Comparative proteomic analysis of human lung telocytes with fibroblasts. J. Cell Mol. Med. 18, 568-589.
115. Zheng Y., Cretoiu D., Yan G., Cretoiu S.M., Popescu L.M., Fang H. and Wang X. (2014c). Protein profiling of human lung telocytes and microvascular endothelial cells using itraq quantitative proteomics. J. Cell Mol. Med. 18, 1035-1059.
116. Zheng Y., Chen X., Qian M., Zhang M., Zhang D., Bai C., Wang Q. and Wang X. (2014d). Human lung telocytes could promote the proliferation and angiogenesis of human pulmonary microvascular endothelial cells in vitro. Mol. Cell Ther. 2, 3.
117. Zhou Q., Wei L., Zhong C., Fu S., Bei Y., Huica R.I., Wang F. and Xiao J. (2015). Cardiac telocytes are double positive for CD34/PDGFRalpha. J. Cell Mol. Med. 19, 2036-2042.
118. Zhu Y., Zheng M., Song D., Ye L. and Wang X. (2015). Global comparison of chromosome X genes of pulmonary telocytes with mesenchymal stem cells, fibroblasts, alveolar type II cells, airway epithelial cells, and lymphocytes. J. Transl. Med. 13, 318.